Pa. Jury Urged To Reject $116M Drug Refund Fraud Charges
A Pennsylvania jury was urged during closing arguments on Thursday to reject charges that the CEO of a drug refund company concocted a scheme to bilk customers, including the U.S. Department...To view the full article, register now.
Already a subscriber? Click here to view full article